Firm Advises Steering Clear Of 'Disappointing' BlueCrest Fund

Sep 14 2012 | 12:17pm ET

Like most hedge funds, BlueCrest Capital Management's listed fund of hedge funds has badly underperformed the broader markets.

The AllBlue Fund is up 4% over the past 12 months, Oriel Securities, which has begun to cover the London-listed vehicle, reports. And Oriel isn’t impressed.

The firm calls that return "disappointing" and gave AllBlue a negative recommendation.

"Over the last three years, returns have been more modest, with the NAV rising by only 20% since September 2009. We think that relatively low volatility in markets has been a factor in the lower returns delivered," Oriel wrote. "Over the past year, the NAV has risen 4%, ahead of the HFRX Global Hedge Fund Index, which has been flat."

Still, Oriel said that the fund, which invests in six underlying BlueCrest funds, "warrants further research and stands out in terms of its relatively high market capitalization (£818 million) and relatively narrow discount."


In Depth

Exotic Assets: Investing In Rare Violins

Jan 17 2017 | 4:43pm ET

By definition, alternative investments include exotic assets far beyond your typical...

Lifestyle

'Tis the Season: Wall Street Holiday Parties Back In Fashion

Dec 22 2016 | 9:23pm ET

Spending on Wall Street holiday parties has largely returned to pre-2008 levels...

Guest Contributor

The Trump Administration: What It Could Mean for Carried Interest

Jan 19 2017 | 5:25pm ET

The arrival of the Trump administration brings the potential for a repeal of the...

 

From the current issue of

Versum Materials (VSM), with a market capitalization of $2.7 billion, enables chipmakers to achieve higher performance at lower cost with enhanced reliability. Versum is a leading global provider of electronic materials for the integrated circuit and flat-panel display markets.